BACKGROUND Recent studies have demonstrated that low and high birth-weight at birth are risk factors of developing diabetes. The aim of this study was to determine if the abnormal birth-weight is related with hyperinsulinemia and elevated index of the Homeostasis Model assessment for Insulin Resistance (HOMA-IR) at birth, in at term newborns. METHODS Newborns with gestational age between 38 a...

Aim: Primary aim of this study is to compare the neonatal and maternal complications women with Gestational Diabetes Mellitus (GDM) treated insulin or followed by diet. Secondary evaluate rate cesarean section indications that.
 Methods: Women GDM were divided into two groups as (n=110) diet (n=200). Demographic data, antenatal follow-up measurements, gestational week at birth type deliver...

INTRODUCTION Little is known about women's views relating to a diagnosis of borderline gestational diabetes mellitus (GDM) and the subsequent management. This study aimed to explore women's experiences after being diagnosed with borderline GDM, their attitudes about treatment, and factors important to them for achieving any lifestyle changes. METHODS We conducted face-to-face, semistructured ...

objective: vitamin d appears to be involved in regulation of glycemic and inflammatory responses in gestational diabetes. the purpose of this study was to compare the serum levels of 25-hydroxyvitamin d (25(oh)d), inflammatory biomarkers and glycemic profile between gestational diabetes mellitus (gdm) and normal glucose tolerance (ngt) pregnant women. materials and methods: in this cross-sectio...

Insulin detemir (IDet) is a relatively new long-acting insulin analog that offers improved absorption pharmacokinetics and slower tissue distribution due to high plasma protein binding (1). As IDet is increasingly used for treatment of insulin-requiring diabetes, including women with type 2 diabetes (who may conceive while being treated with IDet) as well as women with gestational diabetes mell...

Background. A history of gestational diabetes is an important predictor of many metabolic disturbances later in life. Method. Life after gestational diabetes Ahvaz Study (LAGAs) is an ongoing population-based cohort study. Up to February 2016, 176 women with gestational diabetes underwent a 75 g oral glucose tolerance test (OGTT) at 6-12 weeks postpartum in Ahvaz (southwestern of Iran). Gestati...